Healthcare - Press Releases

Date	Title	Company
04-Dec-2019	Volker Koscielny, new Chief Medical Officer and new member of the Management Board at Almirall	Almirall
04-Dec-2019	Clinerion and EvidNet partner to drive healthcare forward by extending their global reach and technologies for real-world data-driven solutions.	Clinerion Ltd.
04-Dec-2019	First UK Clinical Trial Site Open for Recruitment of Diabetic Patients with Chronic Limb-Threatening Ischemia Using Novel Patient-Specific Regenerative Cell Therapy	The University Hospital of Wales
04-Dec-2019	Interview Released Stefan Przyborski, Chairman for SMi’s 3D Cell Culture Conference 2020	SMi Group
04-Dec-2019	Chiesi outlines €350 million investment and announces the development of the first carbon minimal pressurised Metered Dose Inhaler (pMDI) for Asthma and COPD	Chiesi Group
04-Dec-2019	Kancera reports in-depth analysis of the Phase Ib program with KAND567, showing the desired effect on the human immune system	Kancera AB
04-Dec-2019	MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ’s Adoptive Cell Therapy Programs	MaxCyte, Inc.
04-Dec-2019	Aqilion strengthens its portfolio with two innovative pharmaceutical projects in the fields of inflammation and oncology	AQILION AB
04-Dec-2019	MaxCyte and KSQ Therapeutics Announce Development and Commercialization Agreement to Enable the Advancement of KSQ’s Adoptive Cell Therapy Programs	MaxCyte
04-Dec-2019	Panel Discussion on ‘Deep Dive Shortages: The Impact on Patient Safety’ to be held at Parallel Trade 2020	SMi Group
03-Dec-2019	Owkin teams up with NVIDIA and King's College London to deliver AI to hospitals while protecting patient data with Federated Learning	Owkin
03-Dec-2019	Tangerine Medical adopts MPEG-G data format for end-to-end genomic data processing	GenomSys
03-Dec-2019	Cancer – New Inhibitor Effective Where Others Fail	Karl Landsteiner University of Health Sciences
03-Dec-2019	Announces Distribution Agreement with Apex	Ascension Healthcare plc
03-Dec-2019	ASLAN PHARMACEUTICALS ANNOUNCES PRICING OF $12.8 MILLION PUBLIC OFFERING OF AMERICAN DEPOSITARY SHARES	ASLAN Pharmaceuticals
02-Dec-2019	Confo Therapeutics reports grant of two key patents for ConfoBodies™	Confo Therapeutics
02-Dec-2019	ASLAN PHARMACEUTICALS REPORTS POSITIVE PRELIMINARY DATA FROM PROOF-OF-CONCEPT STUDY FOR ASLAN004 TARGETING ATOPIC DERMATITIS	ASLAN Pharmaceuticals
02-Dec-2019	Destiny Pharma to present at the Partnerships to Tackle the Global Challenge of AMR, UK-China AMR Workshop	Destiny Pharma plc
02-Dec-2019	Cambridge Innovation Capital has attracted £1 billion of investment into Cambridge companies	Cambridge Innovation Capital
02-Dec-2019	ABPI appoints Dr Richard Torbett as new Chief Executive	The Association of the British Pharmaceutical Industry (ABPI)